Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Mol Genet Genomics ; 296(1): 131-140, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33052533

RESUMEN

Aegerolysins are small secreted pore-forming proteins that are found in both prokaryotes and eukaryotes. The role of aegerolysins in sporulation, fruit body formation, and in lysis of cellular membrane is suggested in fungi. The aim of the present study was to characterize the biological function of the aegerolysin gene agl1 in the mycoparasitic fungus Trichoderma atroviride, used for biological control of plant diseases. Gene expression analysis showed higher expression of agl1 during conidiation and during growth in medium supplemented with cell wall material from the plant pathogenic fungus Rhizoctonia solani as the sole carbon source. Expression of agl1 was supressed under iron-limiting condition, while agl1 transcript was not detected during T. atroviride interactions with the prey fungi Botrytis cinerea or R. solani. Phenotypic analysis of agl1 deletion strains (Δagl1) showed reduced conidiation compared to T. atroviride wild type, thus suggesting the involvement of AGL1 in conidiation. Furthermore, the Δagl1 strains display reduced antagonism towards B. cinerea and R. solani based on a secretion assay, although no difference was detected during direct interactions. These data demonstrate the role of AGL1 in conidiation and antagonism in the mycoparasitic fungus T. atroviride.


Asunto(s)
Antibiosis/genética , Cuerpos Fructíferos de los Hongos/genética , Proteínas Fúngicas/genética , Regulación Fúngica de la Expresión Génica , Proteínas Hemolisinas/genética , Hypocreales/genética , Esporas Fúngicas/genética , Botrytis/efectos de los fármacos , Botrytis/crecimiento & desarrollo , Pared Celular/química , Mezclas Complejas/farmacología , Cuerpos Fructíferos de los Hongos/efectos de los fármacos , Cuerpos Fructíferos de los Hongos/metabolismo , Cuerpos Fructíferos de los Hongos/patogenicidad , Proteínas Fúngicas/metabolismo , Proteínas Fúngicas/toxicidad , Proteínas Hemolisinas/metabolismo , Proteínas Hemolisinas/toxicidad , Hypocreales/efectos de los fármacos , Hypocreales/metabolismo , Hypocreales/patogenicidad , Deficiencias de Hierro , Filogenia , Enfermedades de las Plantas/microbiología , ARN Mensajero/genética , ARN Mensajero/metabolismo , Rhizoctonia/efectos de los fármacos , Rhizoctonia/crecimiento & desarrollo , Solanum tuberosum/microbiología , Esporas Fúngicas/efectos de los fármacos , Esporas Fúngicas/metabolismo , Esporas Fúngicas/patogenicidad
2.
Toxicon ; 67: 12-6, 2013 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-23462379

RESUMEN

Ribosome-inactivating proteins (RIPs) either single-chain (type 1) or two-chain (type 2) are frequent in plants, often in multiple forms. They are RNA N-glycosidases, have antiviral, antifungal and insecticidal activity. Their expression in plants is increased under stressful conditions. They are investigated for practical applications in medicine and in agriculture. In medicine, RIPs have been linked to, or fused with, appropriate antibodies or other carriers to form "immunotoxins" or other conjugates specifically toxic to the cells target of the carrier, with the aim of eliminating malignant or other undesired cells. In agriculture, it has been observed that an enhanced expression of RIPs confers to plants an increased resistance to viruses, fungi, insects, and also to drought and salinity.


Asunto(s)
Proteínas Inactivadoras de Ribosomas/toxicidad , Proteínas Inactivadoras de Ribosomas/uso terapéutico , Proteínas Algáceas/uso terapéutico , Proteínas Algáceas/toxicidad , Animales , Antifúngicos , Antivirales , Proteínas Bacterianas/uso terapéutico , Proteínas Bacterianas/toxicidad , Proteínas Fúngicas/uso terapéutico , Proteínas Fúngicas/toxicidad , Humanos , Inmunotoxinas/uso terapéutico , Inmunotoxinas/toxicidad , Insecticidas , Control Biológico de Vectores , Proteínas de Plantas/uso terapéutico , Proteínas de Plantas/toxicidad
3.
Future Microbiol ; 7(6): 705-17, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22702525

RESUMEN

Ribosome-inactivating proteins (RIPs) are toxic due to their N-glycosidase activity catalyzing depurination at the universally conserved α-sarcin loop of the 60S ribosomal subunit. In addition, RIPs have been shown to also have other enzymatic activities, including polynucleotide:adenosine glycosidase activity. RIPs are mainly produced by different plant species, but are additionally found in a number of bacteria, fungi, algae and some mammalian tissues. This review describes the occurrence of RIPs, with special emphasis on bacterial RIPs, including the Shiga toxin and RIP in Streptomyces coelicolor recently identified in S. coelicolor. The properties of RIPs, such as enzymatic activity and targeting specificity, and how their unique biological activity could be potentially turned into medical or agricultural tools to combat tumors, viruses and fungi, are highlighted.


Asunto(s)
Proteínas Bacterianas/toxicidad , Proteínas Bacterianas/uso terapéutico , Proteínas Inactivadoras de Ribosomas/toxicidad , Proteínas Inactivadoras de Ribosomas/uso terapéutico , Proteínas Algáceas/toxicidad , Proteínas Fúngicas/toxicidad , Humanos , Proteínas de Plantas/toxicidad , Shigella/metabolismo , Streptomyces coelicolor/metabolismo
4.
Rev. bras. plantas med ; 13(4): 456-466, 2011. ilus, graf, tab
Artículo en Portugués | LILACS | ID: lil-611450

RESUMEN

Este trabalho teve como objetivos avaliar a composição química do óleo essencial de Baccharis tridentata Vahl, as atividades antioxidante e fungitóxica, e estudar a morfologia das estruturas secretoras do óleo essencial presentes na superfície foliar por meio de microscopia eletrônica de varredura (MEV). A extração do óleo essencial foi realizada por hidrodestilação, as análises quantitativas e qualitativas foram executadas por meio de cromatografia em fase gasosa com detector de ionização de chamas (FID) e acoplada à espectrometria de massas, respectivamente. A atividade antioxidante foi realizada empregando-se os métodos de redução do radical estável DPPH e o ensaio de oxidação do sistema β-caroteno/ácido linoleico. As atividades fungitóxicas foram avaliadas utilizando o teste bioanalítico in vitro, sobre a inibição do crescimento micelial dos fitopatógenos Fusarium oxysporum, Colletotrichum gloeosporioides e Rhizoctonia solani. A composição química revelou a presença de 28 compostos, sendo o α-tujeno (22,93 por cento) o constituinte majoritário; não foi observada atividade antioxidante por meio dos ensaios utilizados, no entanto, observou-se atividade fungitóxica sobre o crescimento micelial dos fitopatógenos estudados. Já os estudos da superfície foliar por MEV revelaram a presença de tricomas glandulares em ambas as superfícies abaxial e adaxial.


This study aimed to evaluate the chemical composition and the antioxidant and fungitoxic activities of Baccharis tridentata essential oil, as well as to study the morphology of its secretory structures present on the leaf surface by scanning electron microscopy (SEM). The essential oil was extracted by hydrodistillation; the quantitative and qualitative analyses were performed on a gas chromatograph equipped with a flame ionization detector (FID) and coupled to a mass spectrometer, respectively. The antioxidant activity was determined by the methods of reduction of the DPPH stable radical and oxidation of the β-carotene/linoleic acid system. Fungitoxic activities were assessed by the in vitro bioanalytical test on the inhibition of the mycelial growth of the plant pathogens Fusarium oxysporum, Colletotrichum gloeosporioides and Rhizoctonia solani. The chemical composition revealed the presence of 28 compounds, with α-thujene (22.93 percent) as the major constituent. No antioxidant activity was observed in the tests used; however, there was fungitoxic activity against the mycelial growth of plant pathogens. Leaf surface studies by SEM revealed the presence of glandular trichomes on both abaxial and adaxial surfaces.


Asunto(s)
Antioxidantes , Baccharis/química , Técnicas In Vitro , Microscopía Electrónica de Rastreo , Aceites Volátiles/análisis , Aceites Volátiles/farmacología , Proteínas Fúngicas/toxicidad , Vesículas Secretoras/fisiología , Antifúngicos/análisis , Bioensayo , Cromatografía de Gases y Espectrometría de Masas
5.
FEBS J ; 277(5): 1260-9, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20121947

RESUMEN

A new highly cytotoxic protein, toxophallin, was recently isolated from the fruit body of the death cap Amanita phalloides mushroom [Stasyk et al. (2008) Studia Biologica 2, 21-32]. The physico-chemical, chemical and biological characteristics of toxophallin differ distinctly from those of another death cap toxic protein, namely phallolysin. The interaction of toxophallin with target cells is not mediated by a specific cell surface receptor. It induces chromatin condensation, as well as DNA and nucleus fragmentation, which are typical for apoptosis. However, caspase III inhibitor [benzyloxycarbonyl-Asp(OMe)-fluoromethylketone] did not stop toxophallin-induced DNA fragmentation. Thus, toxophallin uses a caspase-independent pathway of apoptosis induction. In the present study, we applied a complementary approach based on a combination of proteomics and molecular biology tools for the protein identification of toxophallin. The primary structure of toxophallin was partially studied via direct sequencing of its tryptic peptides, followed by PCR-based cloning of the corresponding cDNA. A subsequent bioinformatic search revealed a structural homology of toxophallin with the l-amino acid oxidase of the Laccaria bicolor mushroom. This demonstrates the usefulness of our approach for the identification of proteins in organisms with unknown genomes. We also found a broad substrate specificity of toxophallin with respect to oxidizing selected amino acids. Ascorbic acid inhibited the cytotoxic effect of toxophallin, most likely as a result of scavenging hydrogen peroxide, which is the product of oxidase catalysis. Thus, in addition to highly toxic cyclopeptides and toxic lectin phallolysin, the death cap fruit body contains another cytotoxic protein in the form of an enzyme, namely l-amino acid oxidase.


Asunto(s)
Amanita/química , Proteínas Fúngicas/genética , Proteínas Fúngicas/toxicidad , L-Aminoácido Oxidasa/química , Micotoxinas/genética , Micotoxinas/toxicidad , Secuencia de Aminoácidos , Animales , Antineoplásicos/farmacología , Línea Celular Tumoral , Células/efectos de los fármacos , Clonación Molecular , Humanos , L-Aminoácido Oxidasa/aislamiento & purificación , Leucemia/tratamiento farmacológico , Espectrometría de Masas , Ratones , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
6.
Curr Pharm Biotechnol ; 9(3): 153-60, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18673280

RESUMEN

Ribotoxins constitute a family of toxic extracellular fungal RNases that exert a highly specific activity on a conserved region of the larger molecule of rRNA, known as the sarcin-ricin loop. This cleavage of a single phosphodiester bond inactivates the ribosome and leads to protein synthesis inhibition and cell death. In addition to this ribonucleolytic activity, ribotoxins can cross lipid membranes in the absence of any known protein receptor. This ability is due to their capacity to interact with acid phospholipid-containing membranes. Both activities together explain their cytotoxic character, being rather specific when assayed against some transformed cell lines. The determination of high-resolution structures of some ribotoxins, the characterization of a large number of mutants, and the use of lipid model vesicles and transformed cell lines have been the tools used for the study of their mechanism of action at the molecular level. The present knowledge suggests that wild-type ribotoxins or some modified variants might be used in human therapies. Production of hypoallergenic mutants and immunotoxins designed against specific tumors stand out as feasible alternatives to treat some human pathology in the mid-term future.


Asunto(s)
Proteínas Fúngicas/uso terapéutico , Hongos/enzimología , Factores Inmunológicos/uso terapéutico , Inhibidores de la Síntesis de la Proteína/uso terapéutico , Ribonucleasas/uso terapéutico , Animales , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Proteínas Fúngicas/química , Proteínas Fúngicas/inmunología , Proteínas Fúngicas/toxicidad , Humanos , Hipersensibilidad/tratamiento farmacológico , Factores Inmunológicos/química , Factores Inmunológicos/inmunología , Factores Inmunológicos/toxicidad , Modelos Moleculares , Neoplasias/tratamiento farmacológico , Fosfolípidos/metabolismo , Inhibidores de la Síntesis de la Proteína/química , Inhibidores de la Síntesis de la Proteína/inmunología , Inhibidores de la Síntesis de la Proteína/toxicidad , Ribonucleasas/química , Ribonucleasas/inmunología , Ribonucleasas/toxicidad
7.
Clin Exp Immunol ; 130(1): 19-24, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12296848

RESUMEN

C57BL/6 mice were sensitized to Aspergillus fumigatus 1-week culture filtrate, which is rich in the non-glycosylated allergen Asp f1, a major allergen in allergic bronchopulmonary aspergillosis (ABPA). A comparison of the effect of treatment of allergen challenged mice by intranasal administration of a 60-kDa truncated recombinant form of human SP-D (rfhSP-D) or recombinant full length SP-A (rhSP-A) was undertaken. Treatment with rfhSP-D produced significant reduction in IgE, IgG1 and peripheral blood eosinophilia and treatment with rfhSP-D, but not rhSP-A resulted in a significant reduction in airway hyperresponsiveness as measured by whole body plethysmography. Lung histology revealed less peribronchial lymphocytic infiltration in mice treated with rfhSP-D. Intracellular cytokine staining of spleen homogenates showed increases in IL-12 and IFN-gamma and decrease in IL-4. The level of endogenous mouse SP-D was elevated sixfold in the lungs of sensitized mice and was not affected by treatment with rfhSP-D. Taken with our previous studies, with a BALB/c mouse model of ABPA using a 3-week A. fumigatus culture filtrate, the present results show that rfhSP-D can suppress the development of allergic symptoms in sensitized mice independent of genetic background and using a different preparation of A. fumigatus allergens.


Asunto(s)
Alérgenos/inmunología , Antígenos Fúngicos/inmunología , Aspergilosis Broncopulmonar Alérgica/tratamiento farmacológico , Aspergillus fumigatus/inmunología , Proteínas Fúngicas/inmunología , Proteína D Asociada a Surfactante Pulmonar/uso terapéutico , Administración Intranasal , Alérgenos/toxicidad , Animales , Anticuerpos Antifúngicos/biosíntesis , Anticuerpos Antifúngicos/inmunología , Antígenos Fúngicos/toxicidad , Antígenos de Plantas , Aspergilosis Broncopulmonar Alérgica/inducido químicamente , Aspergilosis Broncopulmonar Alérgica/patología , Hiperreactividad Bronquial/inducido químicamente , Hiperreactividad Bronquial/tratamiento farmacológico , Evaluación Preclínica de Medicamentos , Eosinofilia/inducido químicamente , Eosinofilia/tratamiento farmacológico , Femenino , Proteínas Fúngicas/toxicidad , Humanos , Inmunización , Interferón gamma/análisis , Interleucina-12/análisis , Interleucina-4/análisis , Pulmón/patología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Fragmentos de Péptidos/administración & dosificación , Fragmentos de Péptidos/farmacología , Fragmentos de Péptidos/uso terapéutico , Pletismografía Total , Proteína A Asociada a Surfactante Pulmonar/análisis , Proteína A Asociada a Surfactante Pulmonar/farmacología , Proteína A Asociada a Surfactante Pulmonar/uso terapéutico , Proteína D Asociada a Surfactante Pulmonar/administración & dosificación , Proteína D Asociada a Surfactante Pulmonar/análisis , Proteína D Asociada a Surfactante Pulmonar/química , Proteína D Asociada a Surfactante Pulmonar/farmacología , Proteínas Recombinantes de Fusión/administración & dosificación , Proteínas Recombinantes de Fusión/farmacología , Proteínas Recombinantes de Fusión/uso terapéutico , Especificidad de la Especie , Bazo/química , Bazo/inmunología , Bazo/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA